DGAP-News: CerMed International Expands its Management Team
(firmenpresse) - DGAP-News: CerMed International Inc. / Key word(s): Change of
Personnel
CerMed International Expands its Management Team
03.05.2011 / 12:00
---------------------------------------------------------------------
CONTACT
CerMed International
(831) 920 2275 (o)
info(at)cermedint.com
www.cermedint.com
CerMed International Expands its Management Team
Monterey, CA - CerMed International, Inc. (GMS) based in Monterey, CA has
announced the expansion of its management team. 'We are very pleased to
have closed on phase one of our funding round which allows us to expand our
management team and move the CerMap program forward. All of these
executives bring significant expertise and accomplishments to CerMed. They
are providing the leadership within their respective disciplines to enable
the company to achieve the significant goals that we set for ourselves'
said Peter Gombrich, CEO and Chairman.
Mr. Drew Hofmann, Sr. VP, Business Development has been promoted to
Executive Vice President, Chief Operating Officer for the Company. Mr.
Hofmann has over 20 years of senior 'C' level management experience in both
early and later stage medical device and diagnostics companies. He
obtained a BS degree in Industrial Engineering, and did graduate studies in
International Marketing from the University of Baltimore.
Mr. Michael Perez has joined the company as Chief Financial Officer. He is
a proven financial executive with over 25 years at the senior management
level. He has a demonstrated record of achievement in both public and
private companies, ranging from the start-up phase to large established
corporations. Mr. Perez has taken a prior company public and participated
in several secondary offerings and venture funding rounds. He has strong
investor relations skills having served as the investor contact at various
times in his career. Mr. Perez has a B.S. degree in Accounting from San
Jose State University and an MBA from University of Santa Clara.
Matthew Gombrich, M.D., M.S. has joined the company as Vice President of
Clinical Affairs. Dr. Gombrich has extensive experience in medical affairs
development, clinical trial design and execution focused on advancing
market adoption in the area of infectious disease and cervical cancer
diagnostics. Dr. Gombrich comes to CerMed having served most recently as
President of Viridis Diagnostics. Prior to Viridis Dr. Gombrich was
Director of Clinical Research/Medical Director at Inverness Medical.
During his tenure at Inverness Dr. Gombrich was responsible for advancing
several products in the infectious disease portfolio by structuring phase
IV clinical trials aimed at increasing product visibility, advancing
clinical utility, and expanding the CLIA status to include the products use
in the 'waived' clinical setting. Other responsibilities included liaison
to the FDA for post-market research proposals, Key Opinion Leader
recruitment, clinical education and sales force training in the infectious
disease product offerings. Dr. Gombrich received both his M.D. and M.S.
from Case Western Reserve University in Cleveland, Ohio.
Mr. Steve Roon has joined the company as Vice President of Sales and
Marketing. Mr. Roon has a broad background in sales and marketing
management in the pharmaceutical, research, and clinical diagnostic
markets. Mr. Roon has over 30 years of experience in the sales and
marketing of medical devices and diagnostics. He was Vice President of
Sales and Marketing at Biolog, Inc. a microbiology company focused on
microbial identification and functional genomics. In addition to expanding
the domestic revenues, he also reorganized their European distribution and
established a joint venture in Shanghai which he oversaw as Vice Chairman.
Before joining Biolog, Mr. Roon was Global Vice President of Sales at SenDx
Medical, Inc. He joined this diagnostic startup prior to commercial launch
and his sales team delivered strong international and domestic revenues
before the company was sold to Radiometer Medical A/S.
About CerMed International CerMed International, Inc. is an emerging
global medical device company that develops products and systems that help
improve the health of women worldwide. These lower cost products will aid
in reducing the risk of female reproductive diseases. They will enable
women's health initiatives to be brought to the underserved regions of the
world and empower women to personally take steps to reduce the risk of HIV
and other STD's.
For information: http://www.cermedint.com
Contact: info(at)cermedint.com
Phone: 831-920-2275
###
End of Corporate News
---------------------------------------------------------------------
03.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
122705 03.05.2011
Datum: 03.05.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 33947
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 206 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: CerMed International Expands its Management Team"
steht unter der journalistisch-redaktionellen Verantwortung von
CerMed International Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
